Larissa Bastos

Ms. Larissa Bastos

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CSCristina Oliveira da Silva
Cristina Oliveira da Silva
Camilla HageCamilla Hage
Camilla Hage
JJJonas Johnson
Jonas Johnson
MBMagnus Bäck
Magnus Bäck
ANAnikó Ilona Nagy
Anikó Ilona Nagy
AMAristomenis Manouras
Aristomenis Manouras
Background/Objectives: To assess the association between moderate N-terminal natriuretic peptide (NT-proBNP) and cardiac alterations and prognosis in septuagenarians without heart failure (HF). Methods: From the STROKESTOP II screening study, 230 individuals aged 75/76 years with NT-proBNP < 900 ng/L were randomly selected. Subjects with persistent atrial fibrillation (AF), more than mild valvular disease, or HF were excluded. Echocardiography was performed. NT-proBNP ≥ 125 ng/L and paroxysmal AF (pAF) on thumb ECG were used as grouping variables. Participants were followed up during a median of 5 years for cardiovascular mortality, HF, AF, and cerebrovascular events. Cox regression analysis was employed for prognostic assessment. Results: Three groups were identified: SR ≥ 125 (n = 94, no pAF and NT-proBNP ≥ 125 ng/L), pAF (n = 77, pAF and NT-proBNP ≥ 125 ng/L), and controls (n = 30, no pAF and NT-proBNP < 125 ng/L). NT-proBNP was not associated with structural (left atrial volume and left ventricular (LV) mass) or functional (E/e’, LV strain) alterations in any group (p > 0.05). Cardiovascular risk factors (HR: 4.6; CI = 1.7–12.3; p = 0.002), but not NT-proBNP (HR: 1.9; CI = 0.7–5.1; p = 0.2), entailed a prognostic value for the composite endpoint of HF, AF, and cardiovascular death. Conclusions: In septuagenarians without HF, modest NT-proBNP elevation was not associated with echocardiographic changes or prognosis

5 November 2025 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Open access
LBLarissa Bastos
Larissa Bastos
FAFaris Al‐Khalili
Faris Al‐Khalili
MBMagnus Bäck
Magnus Bäck
AMAristomenis Manouras
Aristomenis Manouras
JEJohan Engdahl
Johan Engdahl
KSKambiz Shahgaldi
Kambiz Shahgaldi
Aim: To investigate left atrial (LA) function assessed by peak atrial longitudinal strain (PALS) in an elderly population with silent paroxysmal atrial fibrillation (PAF) compared to age‐matched control group. Methods: From the STROKESTOP2‐study, patients with newly diagnosed silent PAF were enrolled together in a randomly selected age‐matched control group. All patients had NT‐proBNP levels between 125 and 900 ng/L. Echocardiographic examinations were performed and analyzed offline using dedicated software. In addition to conventional echocardiographic variables, PALS was measured using a two‐dimensional speckle tracking (2D‐ST) biplane. Results: The study population (mean age 76 ± 0.3) demonstrated significantly reduced PALS in patients with PAF ( N = 69) compared to controls ( N = 94) (23.9% ± 6.5% vs 30.7% ± 7.6%, p < 0.001). In the PAF group, 29 (42%) patients had normal LA volume index (LAVI) defined as 34 mL/m 2 . When subgroups with normal LAVI were compared, PALS was reduced in PAF compared to controls (25.1 ± 8.0 vs 31.1 ± 7.8, p = 0.001). NT‐proBNP levels did not differ between the PAF group (median 228 ng/L) and the control group (median: 217 ng/L) ( p = 0.16). In multiple linear regression analysis, left ventricular global longitudinal strain, stroke volume index and LAVI were independent predictors of PALS. Receiver operating characteristic curve identified PALS threshold <22% for predicting risk of silent PAF. Conclusion: PALS was significantly reduced in PAF patients even in the absence of significant LA remodeling. PALS <22% predicts risk for silent PAF in general elderly population. In high‐risk patients PALS could be used for AF screening enrichment.

28 October 2026 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
LBLarissa Bastos
Larissa Bastos
FAFaris Al-Khalili
Faris Al-Khalili
MBMagnus Bäck
Magnus Bäck
AMAristomenis Manouras
Aristomenis Manouras
JEJohan Engdahl Engdahl
Johan Engdahl Engdahl
KSKambiz Shahgaldi
Kambiz Shahgaldi
Purpose: To study left atrial stiffness index (LASI) and left atrial activation time (LA-AT) changes in an older population with silent paroxysmal atrial fibrillation (PAF) compared to age-matched control. Methods: Individuals with newly diagnosed PAF and a randomly selected age-matched control group without AF were enrolled from STROKESTOP2-study. All participants had NT-proBNP levels 125–900 ng/L. TTE examinations were analyzed retrospectively offline using dedicated software. Besides conventional echocardiographic measurements, LA-AT was obtained by measuring the time delay between the onset of the P-wave on ECG and tissue Doppler Á peak wave in lateral LA wall. LASI was calculated as the ratio of left ventricular filling (E/é) to peak atrial longitudinal strain (PALS). Results: Mean age was 76 ± 0.3 years. The PAF group ( n = 67) presented significant increase of LASI (0.41 (0.29–0.60) vs. 0.32 (0.29–0.43), P = 0.001) and prolonged LA-AT (170 (140–180) ms vs. 140 (120–144) ms, P < 0.001) compared to controls ( n = 94). Subgroup analysis in participants with normal LA volume index (LAVI) ≤ 34 ml/m 2 , LASI and LA-AT remained significantly increased/prolonged in PAF ( N = 27) compared to controls ( N = 72). NT-proBNP-levels did not differ between PAF (228 (181–348) ng/L) and controls (216 (156–317) ng/L) ( P = 0.18). ROC curve analysis identified thresholds LASI > 0.54 and LA-AT > 139 msec for discrimination of silent PAF. Conclusion: Indices reflecting LA stiffness and atrial conduction delay were significantly elevated in recently diagnosed PAF patients. LASI and LA-AT thresholds might non-invasively detect early atrial remodeling without structural enlargement in elderly patients with high risk of PAF and mildly increased NT-proBNP levels.

8 March 2024
Verified
Preprint
Open access
LBLarissa Bastos
Larissa Bastos
FAFaris Al-Khalili
Faris Al-Khalili
MBMagnus Bäck
Magnus Bäck
AMAristomenis Manouras
Aristomenis Manouras
JEJohan Engdahl
Johan Engdahl
KSKambiz Shahgaldi
Kambiz Shahgaldi
Purpose: To study left atrial stiffness index (LASI) and left atrial activation time (LA-AT) changes in an older population with silent paroxysmal atrial fibrillation (PAF) compared to age-matched control. Methods: Individuals with newly diagnosed PAF and a randomly selected age-matched control group without AF were enrolled from STROKESTOP2-study. All participants had NT-proBNP levels 125-900 ng/L. TTE examinations were analyzed retrospectively offline using dedicated software. Besides conventional echocardiographic measurements, LA-AT was obtained by measuring the time delay between the onset of the P-wave on ECG and tissue Doppler Á peak wave in lateral LA wall. LASI was calculated as the ratio of left ventricular filling (E/é) to peak atrial longitudinal strain (PALS) Results: Mean age was 76±0.3. The PAF group (n=67) presented significant increase of LASI (0.41 (0.29 – 0.60) vs. 0.32 (0.29 – 0.43), P=0.001) and prolonged LA-AT (170 (140 – 180) ms vs. 140 (120 – 144) ms, P0.33 and LA-AT>139 msec for predicting silent PAF. Conclusions: Indices reflecting LA stiffness and fibrosis were significantly elevated in recently diagnosed PAF patients and elevated in the absence of LA dilatation. LASI and LA-AT thresholds might non-invasively provide additional information in patients with high risk of PAF in general elderly population.